Cargando…

Cystic metastasis of prostate cancer: A case report

RATIONALE: Prostate cancer often metastasizes (most commonly to the pelvic lymph nodes and axial skeleton); however, metastases to the pelvic cavity as a solitary mass are unusual. While metastatic prostate cancer is unconventional in pelvic cavity, cystic pelvic lesions are even more scarce. Accura...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Bei, Bian, Bingyang, Bi, Lirong, Wang, Zhuo, Zhao, Yang, Wang, Jiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320181/
https://www.ncbi.nlm.nih.gov/pubmed/30558081
http://dx.doi.org/10.1097/MD.0000000000013697
_version_ 1783385189701910528
author Zhang, Bei
Bian, Bingyang
Bi, Lirong
Wang, Zhuo
Zhao, Yang
Wang, Jiping
author_facet Zhang, Bei
Bian, Bingyang
Bi, Lirong
Wang, Zhuo
Zhao, Yang
Wang, Jiping
author_sort Zhang, Bei
collection PubMed
description RATIONALE: Prostate cancer often metastasizes (most commonly to the pelvic lymph nodes and axial skeleton); however, metastases to the pelvic cavity as a solitary mass are unusual. While metastatic prostate cancer is unconventional in pelvic cavity, cystic pelvic lesions are even more scarce. Accurate identification of cystic metastasis can be helpful in management of prostate cancer. PATIENT CONCERNS: A 64-year-old male was admitted to our hospital due to urethral irritation symptom and dysuria. DIAGNOSIS: In addition to prostate cancer, abdominal computed tomography (CT) scanning and magnetic resonance imaging (MRI) of the prostate revealed that a cystic mass was located at right pelvic cavity. Histopathological examination diagnosed the pelvic cystic mass as metastasis from prostatic cancer. Immunohistochemistry results demonstrated Calretinin (+), D2-40 (−), Ki-67 (10%+), Vimentin (−), CK-pan (+), CK5/6 (−), WT-1 (−), PSA (+), SALL4 (−), Villin (−), CK20 (−), CK7 (−), PAX-8 (−), and TTF-1 (−). INTERVENTIONS: The cystic mass was removed. Primary cancer of the prostate was reserved as well. After discharge, the patient underwent in a two-year androgen deprivation therapy (ADT) treatment. OUTCOMES: After 13 months of discharge, no disease progression was found in the patient. LESSONS: Although cystic prostate cancer is rare, the occurrence possibility should be considered when cystic lesions are accompanied with prostate cancer.
format Online
Article
Text
id pubmed-6320181
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-63201812019-01-14 Cystic metastasis of prostate cancer: A case report Zhang, Bei Bian, Bingyang Bi, Lirong Wang, Zhuo Zhao, Yang Wang, Jiping Medicine (Baltimore) Research Article RATIONALE: Prostate cancer often metastasizes (most commonly to the pelvic lymph nodes and axial skeleton); however, metastases to the pelvic cavity as a solitary mass are unusual. While metastatic prostate cancer is unconventional in pelvic cavity, cystic pelvic lesions are even more scarce. Accurate identification of cystic metastasis can be helpful in management of prostate cancer. PATIENT CONCERNS: A 64-year-old male was admitted to our hospital due to urethral irritation symptom and dysuria. DIAGNOSIS: In addition to prostate cancer, abdominal computed tomography (CT) scanning and magnetic resonance imaging (MRI) of the prostate revealed that a cystic mass was located at right pelvic cavity. Histopathological examination diagnosed the pelvic cystic mass as metastasis from prostatic cancer. Immunohistochemistry results demonstrated Calretinin (+), D2-40 (−), Ki-67 (10%+), Vimentin (−), CK-pan (+), CK5/6 (−), WT-1 (−), PSA (+), SALL4 (−), Villin (−), CK20 (−), CK7 (−), PAX-8 (−), and TTF-1 (−). INTERVENTIONS: The cystic mass was removed. Primary cancer of the prostate was reserved as well. After discharge, the patient underwent in a two-year androgen deprivation therapy (ADT) treatment. OUTCOMES: After 13 months of discharge, no disease progression was found in the patient. LESSONS: Although cystic prostate cancer is rare, the occurrence possibility should be considered when cystic lesions are accompanied with prostate cancer. Wolters Kluwer Health 2018-12-14 /pmc/articles/PMC6320181/ /pubmed/30558081 http://dx.doi.org/10.1097/MD.0000000000013697 Text en Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle Research Article
Zhang, Bei
Bian, Bingyang
Bi, Lirong
Wang, Zhuo
Zhao, Yang
Wang, Jiping
Cystic metastasis of prostate cancer: A case report
title Cystic metastasis of prostate cancer: A case report
title_full Cystic metastasis of prostate cancer: A case report
title_fullStr Cystic metastasis of prostate cancer: A case report
title_full_unstemmed Cystic metastasis of prostate cancer: A case report
title_short Cystic metastasis of prostate cancer: A case report
title_sort cystic metastasis of prostate cancer: a case report
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320181/
https://www.ncbi.nlm.nih.gov/pubmed/30558081
http://dx.doi.org/10.1097/MD.0000000000013697
work_keys_str_mv AT zhangbei cysticmetastasisofprostatecanceracasereport
AT bianbingyang cysticmetastasisofprostatecanceracasereport
AT bilirong cysticmetastasisofprostatecanceracasereport
AT wangzhuo cysticmetastasisofprostatecanceracasereport
AT zhaoyang cysticmetastasisofprostatecanceracasereport
AT wangjiping cysticmetastasisofprostatecanceracasereport